Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 5, 2018
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
Mon, June 4, 2018
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
[ Mon, Jun 04th 2018
] - WOPRAI
Konstantinos Aprilakis Maintained (BPMC) at Buy with Decreased Target to $103 on, Jun 4th, 2018
Konstantinos Aprilakis of JMP Securities, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $109 to $103 on, Jun 4th, 2018.
Konstantinos has made no other calls on BPMC in the last 4 months.
There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Konstantinos's Rating of Hold.
This is the rating of the analyst that currently disagrees with Konstantinos
- David Nierengarten of "Wedbush" Maintained at Buy with Increased Target to $106 on, Monday, April 16th, 2018
Similar Stocks and Investing Articles
[ Mon, Apr 16th 2018
] - WOPRAI
[ Fri, Jun 14th 2013
] - WOPRAI
[ Tue, Jun 04th 2013
] - WOPRAI
[ Thu, Aug 16th 2012
] - WOPRAI
[ Fri, Jun 29th 2012
] - WOPRAI
[ Thu, Jun 07th 2012
] - WOPRAI
[ Wed, Jun 06th 2012
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI
[ Mon, Apr 16th 2012
] - WOPRAI